Literature DB >> 21253778

Postoperative complications and survival rates for pancreatic cancer patients.

Jana Kaťuchová1, Juray Bober, Jozef Radoňak.   

Abstract

BACKGROUND/AIMS: Surgical resection offers the only potential cure for pancreatic tumor. The goal of the present study is to determine complications associated with pancreatic resection and to describe their influence on the survival rate for pancreatic cancer patients.
MATERIALS AND METHODS: Between 1996 and 2009, the findings of 125 pancreatic cancer patients were analyzed in a prospective trial at the First Department of Surgery, University Hospital in Košice, Slovakia.
RESULTS: The overall mortality rate and morbidity rate were 3.2% (4 patients) and 27% (34 patients), respectively. In patients with postoperative complications, the median survival time was 12 months (range, 8-14 months), in patients without complications - 18 months (range, 15-20 months).
CONCLUSION: The presence of postoperative complications after pancreatic resections has negative influence on the survival rate for pancreatic cancer patients. Patients with a small pancreatic duct size (<3 mm) or a soft pancreatic remnant were at high risk of pancreatic leakage and postoperative complications.

Entities:  

Mesh:

Year:  2011        PMID: 21253778     DOI: 10.1007/s00508-010-1513-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  15 in total

1.  Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.

Authors:  Dean Bogoevski; Emre F Yekebas; Paulus Schurr; Jussuf T Kaifi; Asad Kutup; Andreas Erbersdobler; Klaus Pantel; Jakob R Izbicki
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 2.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study.

Authors:  Claudio Bassi; Massimo Falconi; Enrico Molinari; Roberto Salvia; Giovanni Butturini; Nora Sartori; William Mantovani; Paolo Pederzoli
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 4.  Delayed gastric emptying: the state of the highest level of evidence.

Authors:  L William Traverso; Yasushi Hashimoto
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-06-06

5.  Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; P K Sauter; J Coleman; T A Sohn; K A Campbell; M A Choti
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 6.  Current standards of surgery for pancreatic cancer.

Authors:  N Alexakis; C Halloran; M Raraty; P Ghaneh; R Sutton; J P Neoptolemos
Journal:  Br J Surg       Date:  2004-11       Impact factor: 6.939

7.  Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.

Authors:  Markus W Büchler; Markus Wagner; Bruno M Schmied; Waldemar Uhl; Helmut Friess; Kaspar Z'graggen
Journal:  Arch Surg       Date:  2003-12

8.  A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy.

Authors:  C J Yeo; J L Cameron; M M Maher; P K Sauter; M L Zahurak; M A Talamini; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

9.  Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area.

Authors:  Elizabeth A Holly; Indranushi Chaliha; Paige M Bracci; Manjushree Gautam
Journal:  Clin Gastroenterol Hepatol       Date:  2004-06       Impact factor: 11.382

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  2 in total

1.  Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy.

Authors:  Salah Binziad; Ahmed A S Salem; Gamal Amira; Farouk Mourad; Ahmed K Ibrahim; Tariq Mohamed Abdel Manim
Journal:  South Asian J Cancer       Date:  2013-07

Review 2.  Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

Authors:  Birgir Gudjonsson
Journal:  HPB Surg       Date:  2016-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.